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Abstract
The Origin Recognition Complex (ORC) is a 6-subunit 
complex which binds to the origin of replication in all 
eukaryotes. When ORC is bound at origins of replication, it 
recruits the pre-replication complex to initiate DNA 
replication. The smallest subunit of ORC, Orc6, is essential 
in DNA replication and mitosis. Evidence from previous 
experiments shows that Orc6 is also involved in the DNA 
damage response. Additionally, Origin Recognition 
Complex-Associated (ORCA) is a pre-replication complex 
protein which localizes to regions of heterochromatin and 
stabilizes ORC. The aim of this study was to further define 
the role of Orc6 and ORCA by identifying unknown proteins 
which interact with them. With the goal of identifying these 
interacting proteins, we utilized a newly developed 
approach called BioID. The BioID method involves the 
expression of fusion proteins containing the BirA biotin 
ligase. We therefore stably expressed the BirA-HA-Orc6, 
BirA-HA-ORCA, or BirA-HA-EYFP fusion protein in 
mammalian cells and potential Orc6- and ORCA-interacting 
proteins were labeled upon subsequent addition of biotin to 
the cells. Finally, we performed a pull-down of biotinylated 
proteins which will be analyzed by mass spectrometry and 
we will further validate novel interacting proteins that may 
be identified by this method.
Experimental Approach
▪ Cloning of BirA-HA-ORC6, BirA-HA-ORCA, and BirA-
HA-EYFP plasmids
▪ Stable transfection of BirA-HA-Orc6, BirA-HA-ORCA, 
and BirA-HA-EYFP
▪ Validation of biotinylation of proteins in the BirA-HA-
Orc6, BirA-HA-ORCA, and BirA-HA-EYFP stable cell 
lines
Figure 1. BirA-SETD2 plasmid map (10,061 bp): 
The BirA-HA-Orc6, BirA-HA-ORCA, and BirA-HA-EYFP plasmids 
were cloned using the backbone of the BirA-SETD2 plasmid. As 
shown here, the BirA-SETD2 plasmid contains the sequence for the 
BirA biotin ligase as well as the puroR gene, which confers resistance 
to the drug puromycin. The SETD2 gene was replaced with the gene 
of interest (ORC6, ORCA, or EYFP) along with an HA tag sequence 
during the cloning procedures.
Results
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Figure 2. Maps of cloned plasmids: (A) BirA-HA-Orc6 plasmid cloning 
product, (B) BirA-HA-ORCA plasmid cloning product, (C) BirA-HA-EYFP 
plasmid cloning product. Note that the genes of interest were inserted 
adjacent to the BirA sequence along with the HA tag sequence.
Figure 3. Validation of the 
BirA-HA-Orc6 and BirA-
HA-ORCA plasmid 
constructs: (A) Restriction 
digestion of BirA-HA-Orc6 
plasmid cloning product 
using EcoRI and BamHI
restriction enzymes. (B) 
Restriction digestion of BirA-
HA-ORCA plasmid cloning 
product using NotI and 
BamHI restriction enzymes. 
These figures are courtesy 
of Yo-Chuen Lin, graduate 
student in the Supriya
Prasanth laboratory.
Figure 4. Validation of stable transfection of BirA-HA-EYFP: A 
Western blot using the HA tag primary antibody was performed on cell 
lysate obtained from the BirA-HA-EYFP stable cell line. This 
experiment yielded the data shown here, and the arrow indicates the 
location of bands corresponding to the molecular weight of BirA-HA-
EYFP. Bands associated with this MW are found in the BirA-HA-EYFP 
stable cell line but not in the U2OS control sample.
Figure 5. Validation of stable transfection of BirA-HA-Or6 and BirA-
HA-ORCA: (A) Data from Western blot experiment performed on cell 
lysates from BirA-HA-Orc6 and BirA-HA-ORCA stable cell lines using the 
HA tag primary antibody. The arrows indicate locations of bands 
corresponding to BirA-HA-Orc6 or BirA-HA-ORCA. (B) Data from 
Western blot experiment performed on cell lysate from the BirA-HA-Orc6 
stable cell line using the Orc6 primary antibody. The arrows indicate 
locations of bands corresponding to BirA-HA-Orc6 or endogenous Orc6. 
(C) Data from Western blot experiment performed on cell lysate from the 
BirA-HA-ORCA stable cell line using the ORCA primary antibody. The 
arrows indicate locations of bands corresponding to BirA-HA-ORCA or 
endogenous ORCA. Note that the “#1” and “#2” indicate two separate 
samples from the same stable cell line. These figures are courtesy of Yo-
Chuen Lin, graduate student in the Supriya Prasanth laboratory. 
Figure 6. Validation of biotinylation in BirA-HA-Orc6, BirA-HA-
ORCA, and BirA-HA-EYFP stable cell lines: (A) Immunoblot of cell 
lysate from the BirA-HA-Orc6 stable cell line using streptavidin-HRP. (B) 
Immunoblot of cell lysate from the BirA-HA-ORCA stable cell line using 
streptavidin-HRP. (C) Immunoblot of cell lysate from the BirA-HA-EYFP 
stable cell line using streptavidin-HRP. 
Figure 7. Validation of biotinylation in pull-down products: (A) 
Immunoblot of pull-down products which originated from the BirA-HA-
Orc6 stable cell line using streptavidin-HRP. (B) Immunoblot of pull-
down products which originated from the BirA-HA-EYFP stable cell 
line using streptavidin-HRP.
Conclusions
▪ We successfully cloned three separate plasmids 
containing the BirA-HA-Orc6, BirA-HA-ORCA, and BirA-
HA-EYFP fusion genes, respectively.
▪ We successfully established the stable expression of each 
of our BioID fusion proteins.
▪ We validated that the BioID fusion proteins could label 
proximal proteins with biotin.
▪ Future Directions: We will further analyze candidate 
proteins that are identified by mass spectrometry analysis 
of pull-down products originating from the BirA-HA-Orc6 or 
BirA-HA-ORCA stable lines. This will be accomplished by 
first confirming the presence of candidate proteins in BirA-
HA-Orc6 or BirA-HA-ORCA pull-down products.
